Use our chat feature to speak with one of our expert consultants who can help you identify if medical cannabis can help you.
3 min read
Sam North
At Releaf, we have streamlined the triage process to ensure our patients receive the highest quality care and treatment in the shortest possible time, including prescription delivery.
Once you have completed our free and easy eligibility checker, the Releaf triage process then involves the following:
Our multidisciplinary team of experts, including specialist doctors, nurses, and patient support staff, work together to evaluate each patient's unique needs and provide personalised treatment plans.
If everything is in order, the approved script is then released to our pharmacy (Xeal dispensary). You will receive an email and an SMS notifying you that your prescription is ready for payment. Once payment has been processed, the experienced pharmacists begin preparing the medication, which will then be sent out for delivery.
The initial consultation is the first step in determining whether cannabis-based medicine is the right treatment for your condition. Instead of following a rigid set of questions, our specialists will engage in an open dialogue. They will review your medical history and records and ask a range of questions. This thorough conversation allows the specialist to make a well-informed decision about the suitability of medical cannabis for your individual needs.
Accessing your medical records is a crucial step in our triage process. This lets our specialists fully understand your medical history, current medications and health issues, and any potential medication contraindications.
The MDT review is an essential step in our triage process. It involves a team of experts reviewing your case as a whole and discussing the best possible treatment options for you. This collaborative approach ensures that all aspects of your health are taken into consideration and that the most suitable treatment plan is recommended for your specific needs.
Every specialist, nurse, and patient support staff member in our MDT is highly trained and knowledgeable about the application of medical cannabis, and they all bring different perspectives and expertise to the review process. This holistic approach allows us to provide comprehensive and personalised care for each patient.
Supply chain issues have plagued the UK medical cannabis industry, and many patients have experienced long waiting times for their medication. That's why we have recently partnered with Glass PharmsⓇ .
Glass Pharms has produced the first UK-grown medical cannabis available to UK patients, heavily reducing the delivery time. We no longer need to be reliant on overseas medical cannabis supplies, and patients can receive their medication quickly after approval.
It is important to seek medical advice before starting any new treatments. The patient advisors at Releaf are available to provide expert advice and support. Alternatively, click here to book a consultation with one of our specialist doctors.
Get comprehensive care, convenience, and confidence with an all-in-one treatment plan.
Am I eligible?Sam North, a seasoned writer with over five years' experience and expertise in medicinal cannabis, brings clarity to complex concepts, focusing on education and informed use.
All of our articles are written by medical cannabis experts, guided by strict sourcing guidelines, and reference peer-reviewed studies and credible academic research. Our expert clinical team and compliance specialists provide valuable insights to ensure accuracy when required. Learn more in our editorial policy.
Need more help?
Around the world, 1.3 billion, or 1 in 6, people live with a disability - yet many face barriers when accessing adequate healthcare services. At Releaf, it's important to us to participate in events like International Day of Persons with Disabilities, and so that’s exactly what we’re doing.
Lucy MacKinnon
World AIDS Day takes place every year on the 1st of December, and has done since 1988. We’d like to honour this year's campaign by raising the awareness of one treatment option many affected by HIV aren’t even aware is available to them: medical cannabis.
Lucy MacKinnon
Last year, our representative research found 68% of UK adults would consider medical cannabis treatment if their doctor recommended it, but around 1 in 4 said they would be apprehensive about, and perhaps discouraged by, the costs involved.
Lucy MacKinnon
